Patent Assignment
Reel/Frame 032258/0937
Change of Name
Recorded: 2014-02-20
Pages: 30
Assignor
DOV PHARMACEUTICAL, INC.
Executed: 2010-07-20
Assignee
EUTHYMICS BIOSCIENCE, INC.
43 THORNDIKE STREET, SUITE S1-3, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Properties
(2)
Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
Application:
11/493,431 →
Publication:
US 2007/0082940
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Application:
12/334,432 →
Publication:
US 2009/0233978
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 19, 2007
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019578/0394 →
Assignment of Assignor's Interest
Aug 19, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019713/0936 →
Assignment of Assignor's Interest
Feb 20, 2014
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 032258/0128 →
Assignment of Assignor's Interest
Feb 20, 2014
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 032260/0071 →
Assignment of Assignor's Interest
Oct 28, 2016
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 040512/0162 →
Merger
Dec 13, 2017
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 044867/0815 →